5 Minutes With Pamela B. Morris, MD
This month we speak with one of the Session Chairs of Medscape’s upcoming 4th Annual Going Back to the Heart of Cardiology, Dr. Pamela B. Morris.
Dr. Morris candidly shares perspectives and critical insights on both personal and professional topics, including some of the latest breakthroughs in cardiology, the best tool in her clinical arsenal, best advice she’s received, and what to look forward to in the two sessions she chairs at the HOC— Cardiometabolic Disease: Parts 1 & 2. Read, enjoy, and register!
Last month, the faculty of Medscape’s Going Back to the Heart of Cardiology dished on the most critical new (and on the horizon) cardiology-related advances and what HOC attendees will come away with regarding these advances and more. If you missed it, click here!
Also check out this issue’s Pulse, with articles from the Journal of the American Heart Association, Circulation, European Heart Journal, Journal of the American College of Cardiology, Cardiology News, and New England Journal of Medicine.
Thank you to Dr. Morris for her time, candor, and expertise as faculty and in this interview. Don’t forget to register here for Medscape’s 2023 Going Back to the Heart of Cardiology conference for the best 2023 CME opportunity available! Please contact me at colleen@cmhadvisors.com with any comments and/or suggestions! –Colleen Hutchinson
Housekeeping: CME 2023—Add this to your calendar now and sign up for updates:
Going Back to the Heart of Cardiology Conference (4th Annual)
Saturday-Monday December 8-10, 2023; Anaheim, California
To register, click here!
- Sessions 1-6: Cardiopulmonary Failure; Atherosclerosis and Thrombosis; and Cardiometabolic Disease; Electrical Failure; Valvular Disease: Special Topics in Cardiology
- View Agenda: https://www.heartofcardio.com/agenda!
5 Minutes With… Pamela Bowe Morris, MD
Dr. Morris is Professor of Medicine, Cardiology, Diplomate, American Board of Clinical Lipidology, Director, Seinsheimer Cardiovascular Health Program, The Medical University of South Carolina, Charleston, South Carolina.
What do you anticipate attendees coming away with from the two sessions you chair— Cardiometabolic Disease: Parts 1 & 2 at the HOC?
Dr. Morris: With the global epidemic of obesity and associated cardiometabolic diseases, it is imperative that clinicians have the skills and practice tools they need to help patients achieve optimal cardiovascular health. During the Cardiometabolic Sessions at the 3rd Annual Medscape Heart of Cardiology, experts will review strategies to support patients as they implement healthy lifestyle changes and consider pharmacological approaches to weight management and obesity. Clinical challenges to be explored include angina without obstructive coronary disease, resistant hypertension, renal protection in cardiometabolic diseases, the intersection of diabetes and heart failure, and evolving therapies for management of dyslipidemias.
What advice would you give the medical school student who plans to specialize in cardiology?
Dr. Morris: Choose the specialty that most interests you, but don’t forget to incorporate into that decision how important sleep is to you (from the perspective of your 45-year-old self, not your 25-year-old self!).
Most critical new (or on the horizon) cardiology-related advance:
Dr. Morris: ARNI and SGLT2 inhibitors.
What are some of the latest breakthroughs in cardiology and research that you think are/will be of great import to attendees who want to return to their practices armed with practical and useful treatment information?
Dr. Morris: Breakthroughs in cardiometabolic health have been so successful in transforming the cardiovascular disease prevention landscape that it can be difficult for clinicians and patients to keep up with evolving therapies and guidelines. Novel agents have emerged for renal protection in cardiorenal disease, management of diabetes, prevention of heart failure and ischemic heart disease, and treatment of complex dyslipidemias and rare lipid disorders. During the Cardiometabolic Sessions at the 3rd Annual Medscape "Heart of Cardiology", experts will provide guidance and give clinicians greater confidence when prescribing newer agents.
Advice that has helped in my career:
Dr. Morris: Be true to yourself and reevaluate your goals and priorities every 5 years.
Best device/tool in my clinical arsenal:
Dr. Morris: The HF Guidelines!
The Pulse
Cardiology News: Durable LVAD for advanced HF still underutilized
NEJM Original Article: Optical Coherence Tomography–Guided versus Angiography-Guided PCI
Medical Intelligence Quiz: Myocardial Infarction Risk Factors